|
Market Closed -
Boerse Muenchen
16:43:19 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 136.80 EUR | +7.60% |
|
+8.78% | +420.15% |
| 09-16 | Moderna Insider Sold Shares Worth $11,691,420, According to a Recent SEC Filing | MT |
| 09-16 | Ebola response making progress in Congo, but outbreak 'far from over,' WHO says | RE |
| Market Cap | 63.11B 54.97B 52.02B 47.27B 88.3B 6,044B 88.74B 620B 240B 3,072B 237B 232B 9,833B | P/E 2026 * |
-18.9x | P/E 2027 * | -33x |
|---|---|---|---|---|---|
| Enterprise Value | 59.45B 51.78B 49.01B 44.53B 83.19B 5,694B 83.6B 584B 226B 2,894B 223B 218B 9,264B | EV / Sales 2026 * |
28.3x | EV / Sales 2027 * | 25x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
|
Tradegate
| 0QF | Real-time | |
|
London S.E.
| 0A45 | Delayed | |
|
Xetra
| 0QF | Delayed | |
|
Boerse Muenchen
| 0QF | Real-time | |
|
Borsa Italiana
| 1MRNA | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| 0QF | Delayed | |
|
Deutsche Boerse AG
| 0QF | Delayed | |
|
Wiener Boerse
| MRNA | End-of-day quote | |
|
Mexican S.E.
| MRNA * | End-of-day quote | |
|
CBOE
| 0A45 | Real-time | |
|
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
|
Lima
| MRNAUS | End-of-day quote | |
|
Swiss Exchange
| MRNA | Delayed | |
|
Swiss Exchange
| MRNA | Delayed |
Last Transcript: Moderna, Inc.
| 1 day | +7.60% | ||
| Current month | +16.25% | ||
| 1 month | +148.05% | ||
| 3 months | +153.57% | ||
| 6 months | +202.62% | ||
| Current year | +420.15% |
| 1 month | 53.94 |  | 143.2 |
| Current year | 25.38 | | 143.2 |
| 1 year | 20.72 | | 143.2 |
| 3 years | 20.18 | | 155.3 |
| 5 years | 20.18 | | 389.5 |
| 10 years | 14.22 | | 430.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 2011-02-28 |
James Mock
DFI | Director of Finance/CFO | 49 | 2022-09-05 |
Stephen Hoge
PSD | President | 50 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 2012-01-31 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 2011-02-28 |
Francois Nader
BRD | Director/Board Member | 69 | 2019-12-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.60% | +8.78% | - | - | 58.14B | |
| +1.92% | -0.48% | +34.83% | -4.12% | 77.35B | |
| -0.97% | +5.31% | -11.28% | -33.76% | 59.58B | |
| +8.55% | +15.70% | +532.28% | +37.94% | 58.14B | |
| -0.92% | -1.90% | -10.99% | +24.21% | 47.62B | |
| +1.21% | +3.42% | +2.76% | +147.74% | 45.34B | |
| +1.41% | +1.68% | +51.20% | -14.03% | 31.92B | |
| +2.30% | +3.52% | +50.50% | +104.03% | 25.29B | |
| +2.86% | +5.77% | +1.64% | +148.31% | 20.88B | |
| +1.46% | +1.60% | +62.58% | +98.84% | 15.64B | |
| Average | +1.56% | +2.15% | +79.28% | +56.57% | 42.42B | |
| Weighted average by Cap. | +1.48% | +2.93% | +95.60% | +38.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.83B 1.73B 1.57B 2.94B 201B 2.95B 20.63B 7.98B 102B 7.89B 7.72B 327B | 2.44B 2.12B 2.01B 1.83B 3.41B 233B 3.43B 23.94B 9.26B 119B 9.16B 8.95B 380B |
| Net income | -3.31B -2.89B -2.73B -2.48B -4.64B -317B -4.66B -32.53B -12.58B -161B -12.44B -12.17B -516B | -1.94B -1.69B -1.6B -1.46B -2.72B -186B -2.73B -19.09B -7.38B -94.65B -7.3B -7.14B -303B |
| Net Debt | -3.65B -3.18B -3.01B -2.74B -5.11B -350B -5.14B -35.87B -13.87B -178B -13.72B -13.42B -569B | -2.17B -1.89B -1.79B -1.63B -3.04B -208B -3.05B -21.31B -8.24B -106B -8.15B -7.97B -338B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
- 0QF Stock
Select your edition
All financial news and data tailored to specific country editions
